The meeting will start promptly at 10:00 and is expected to finish at approximately 14:00
Please note that this agenda is subject to change prior to the meeting.
1. Welcome and introduction to format of meeting
3. Any other business
4. Minutes from the last Committee meeting held on Wednesday 27 August 2014
5. Appraisal of rivaroxaban for the prevention of adverse outcomes in patients after the acute management of acute coronary syndrome [ID532]
5.1. Declarations of interest - Part 1 only (open session)
5.2. Introduction by the Chair, Dr Jane Adam - Part 1 only (open session)
5.3. presentation by the Lead team, Dr John Watkins and Professor Aileen Clarke- Part 1 and Part 2 (open and closed session)
5.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)
Next Technology Appraisal (Committee A) Meeting: Tuesday 28th October 2014, 10:00am, the Royal College of General Practitioners, 30 Euston Square, London, NW1 2HD
You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.
The closing date for registration is Wednesday 10 September 2014 at 5pm. Please note that it may not be possible to accept late registration requests.
Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Melinda Kay
Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email email@example.com Further information about conducting research is also available in our Common Questions and Answers about meetings in public document